论文部分内容阅读
作者们对491例喉癌行放疗和综合治疗的效果进行了回顾性研究,提出了喉癌对放射线敏感程度的临床和细胞学标准。这些患者分为两组:A组250例,单行放疗治愈,并经3～20年的观察。B组241例,放疗无效。作者们根据癌肿部位、生长方式、溃疡发生率、声带活动情况和颈淋巴结转移等方面,将上两组比较分析如下: 部位:位于杓会厌皱襞:A组为8.4±1.8％:B组为33.6±3.1％。喉室:A组为17.6±2.4％;B组为55.6±3.2％。声门下:A组为5.2±1.4％;B组为19.5±2.6％。癌肿向喉咽扩张:A组为1.6±0.8％,B组为39.4±3.1％。生长方式:A组以外生性生长为主,占59.2±3.2％;B组以内生性生长为主,占70.9±2.9％。溃疡发生率:A组为15.2±2.3％;B组为50.2±4.2％。声带活
The authors performed a retrospective study of the radiotherapy and combined therapies in 491 patients with laryngeal cancer and proposed clinical and cytological criteria for radiosensitivity in laryngeal cancer. These patients were divided into two groups: Group A 250 patients, single-line radiotherapy to cure, and after 3 to 20 years of observation. Group B 241 cases, radiotherapy invalid. The authors compared the above two groups according to the location of the tumor, growth pattern, ulcer incidence, vocal cord activity, and cervical lymph node metastasis. Location: Located in the bullhelic epiglottis: 8.4 ± 1.8% in group A: 33.6 ± 3.1%. Throat chamber: A group was 17.6 ± 2.4%; B group was 55.6 ± 3.2%. Subglottic: A group was 5.2 ± 1.4%; B group was 19.5 ± 2.6%. The spread of cancer to the hypopharynx was 1.6 ± 0.8% in group A and 39.4 ± 3.1% in group B. Growth mode: A group of mainly outside the growth of the students, accounting for 59.2 ± 3.2%; B group mainly endogenous growth, accounting for 70.9 ± 2.9%. The incidence of ulcer was 15.2 ± 2.3% in group A and 50.2 ± 4.2% in group B. Vocal live